Ripple Science
Dan Watkins serves as the Chief Executive Officer of Pelagos Pharma, focusing on drug development aimed at modulating cellular metabolism to address obesity, enhance muscle function, and combat various metabolic and age-related diseases. In addition, Dan holds the position of Venture Partner at Mercury, with a concentration on biotech and AI/ML applications in life sciences. Dan is also the Managing Director at OmniScience, overseeing strategy and partnerships, and previously held the role of Chief Executive Officer at Mercury Data Science, which provides AI/ML strategy and software solutions for healthcare. Dan Watkins earned a PhD in Materials Science and Engineering from Carnegie Mellon University and a BS in Materials Science from Rice University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ripple Science
Ripple Science accelerates clinical research with its secure HIPAA-compliant suite of tools. By adapting sales and marketing automation to the processes of patient recruitment and retention, Ripple helps its customers recruit more participants, faster and reduces patients lost to follow-up.